BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240130T083000
DTEND;TZID=America/Vancouver:20240201T170000
DTSTAMP:20260410T043358
CREATED:20231218T211105Z
LAST-MODIFIED:20231218T211105Z
UID:28418-1706603400-1706806800@scienceinboston.com
SUMMARY:7th DDR Inhibitors Summit
DESCRIPTION:DDR inhibitor development is evolving rapidly\, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to DDR inhibitors\, yet more pharmaceutical companies like Roche and Gilead are diving into this therapeutic strategy; biotech companies like Artios and IDEAYA remain dedicated to delivering safe and effective treatments to patients. The unmet need for cancer therapies reinforces the critical importance for the community to unite at the 7th Annual DDR Inhibitors Summit in Boston\, January 2024\, to advance first-in-class oncology treatments for patients. This year’s conference has undergone a renovation to maximize your experience\, featuring a new biomarkers pre-conference focus day with the goal of demystifying patient stratification and target ID. Two tracks for the main conference days follow\, covering early discovery of next-generation targets and clinical updates. Join 150 peers in oncology innovation\, synthetic lethality\, medicinal chemistry\, and clinical development\, at the exclusive DDR Inhibitors conference – the sole industry-led event providing unmatched depth and insight into your challenges. \n  \nFind out more!
URL:https://scienceinboston.com/event/7th-ddr-inhibitors-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2023/12/large.png
END:VEVENT
END:VCALENDAR